Micrometastases in sentinel lymph node in a multicentric study: Predictive factors of nonsentinel lymph node involvement - Groupe des Chirurgiens de la Federation des Centres de Lutte Contre Le Cancer

Journal of Clinical Oncology

Volumn 24, Issue 12, 2006, Pages 1814-1822

  Houvenaeghel, Gilles ^a   Nos, Claude ^b   Mignotte, Hervé ^b   Classe, Jean Marc ^b   Giard, Sylvie ^b   Rouanet, Philippe ^b   Lorca, Frédérique Penault ^b   Jacquemier, Jocelyne ^b   Bardou, Valérie Jeanne ^b  

^a INSTITUT PAOLI CALMETTES   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST TUMOR; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE; TUMOR VOLUME; CLINICAL TRIAL; FEMALE; LYMPHADENECTOMY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 33646368959     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.03.3225     Document Type: Article

References (68)

1. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-398, 1994
2. Krag D, Weaver D, Ashikaga T, et al: The sentinel node in breast cancer: A multicenter validation study. N Engl J Med 339:941-946, 1998
3. Schwartz GF, Giuliano AE, Veronesi U: The Consensus Conference Committee: Proceeding of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, PA. Cancer 94:2542-2551, 2002
4. Arnaud S, Houvenaeghel G, Guiramand J, et al: Patients' and surgeons' perspectives on axillary surgery for breast cancer. Eur J Surg Oncol 30:735-743, 2004
5. Turner RR, Chu KU, Qi K, et al: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 89:574-581, 2000
6. Liang WC, Sickle-Santanello BJ, Nims TA: Is a completion axillary dissection uindicated for micrometastases in the sentinel lymph node? Am J Surg 182:365-368, 2001
7. Marin C, Mathelin C, Neuville A, et al: Sentinel lymph node biopsy with micrometastases in breast cancer: Histological data and surgical implications. Bull Cancer 90:459-465, 2003
8. Mignotte H, Treilleux I, Faure C, et al: Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur J Surg Oncol 28:623-626, 2002
9. Weiser MR, Montgomery LL, Tan LK, et al: Lymphovascular invasion enhances the prediction of nonsentinel node mestastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 8:145-149, 2001
10. Nos C, Harding-Mackean C, Freneaux P, et al: Predicting positivy of non-sentinel axillary nodes in breast cancer patients with sentinel node metastases. Br J Surg 90:1354-1360, 2003
11. Viale G, Maiorano E, Mazzarol G, et al: Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 92: 1378-1384, 2001
12. Saidi RF, Dudrick PS, Remine SG, et al: Non-sentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 70:101-105, 2004
13. Dabbs DJ, Fung M, Landsittel D, et al: Sentinel lymph node micrometastasis as a predictor of axillary tumor burden. Breast J 10:101-105, 2004
14. Giard S, Baranzelli MC, Robert D, et al: Surgical implications of sentinel node with micrometastatic disease in invasive breast cancer. Euro J Surg Oncol 20:929-929, 2004
15. Zavagno G, Luca de Salvo G, Bozza F, et al: Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer. Breast Cancer Res Treat 86:171-179, 2004
16. McCready DR, Yong WS, Ng AKT, et al: Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates. J Natl Cancer Inst 96:873-875, 2004
17. Changsri C, Prakash S, Sandweiss L, et al: Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Breast J 10:392-397, 2004
18. Dowlatshahi K, Fan M, Snider HC, et al: Lymph node micrometastases from breast carcinoma: Reviewing the dilemma. Cancer 80:1188-1197, 1997
19. Cserni C, Amendoeira I, Apostolikas N, et al: Pathologic work-up of sentinel lymph nodes in breast cancer: Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39:1654-1667, 2003
20. Abdessalam SF, Zervos EE, Prasad M, et al: Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 182:316-320, 2001
21. Chu KU, Turner RR, Hansen NM, et al: Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol 6:756-761, 1999
22. Fleming FJ, Kavanagh D, Crotty TB, et al: Factors affecting metastasesto non-sentinel lymph nodes in breast cancer. J Clin Pathol 57:73-76, 2004
23. Hwang RF, Krishnamurthy S, Hunt KK, et al: Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10:248-254, 2003
24. Kamath VJ, Giuliano R, Dauway EL, et al: Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla. Arch Surg 136:688-692, 2001
25. Mori M, Mimori K, Inoue H, et al: Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 55:3417-3420, 1995
26. Hermanek P, Hutter RV, Sobin LH, et al: Classification of isolated tumor cells and micrometastasis. Cancer 86:2668-2673, 1999
27. Veronesi U, Paganelli G, Viale G, et al: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546-553, 2003
28. Naik AM, Fey J, Gemignani M, et al: The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: A follow-up study of 4008 procedures. Ann Surg 240:462-471, 2004
29. Reynolds C, Mick R, Donohue JH, et al: Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 17:1720-1726, 1999
30. Cserni G, Gregori D, Merletti F, et al: Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91:1245-1252, 2004
31. Czerniecki BJ, Scheff AM, Callans LS, et al: Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 85:1098-1103, 1999
32. Houvenaeghel G, Martino M, Jacquemier J, et al: Risk of stage underestimation of breast cancer by sentinel lymph node biopsy method. Bull Cancer 90:467-473, 2003
33. Van Zee KJ, Manasseh DME, Bevilacqua JLB, et al: A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140-1151, 2003
34. Canavese G, Gipponi M, Catturich A, et al: Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients. J Surg Oncol 77:81-87, 2001
35. Rahussen FD, Pijpers R, Van Diest PJ, et al: The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surg 128:6-12, 2000
36. Sachdev U, Murphy K, Derzic A, et al: Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg 183:213-217, 2002
37. Joseph KA, El-Tamer M, Komenaka I,: Predictors of sentinel node metastasis in patients with breast cancer after sentinel node metastasis. Arch Surg 139:648-651, 2004
38. Chua B, Ung O, Taylor R: Treatment implications of a positive sentinel lymph node biopsy for patients with biopsy for patients with early-stage breast carcinoma. Cancer 92:1769-1774, 2001
39. Viale G, Maiorano E, Pruneri G, et al: Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241:319-325, 2005
40. Freneaux P, Nos C, Vincent-Salomon A, et al: Histological detection of minimal metastatic involvement in axillary sentinel nodes: A rational basis for a sensitive methodology usable in daily practice. Mod Pathol 15:641-646, 2002
41. Noguchi M: Therapeutic relevance of breast cancer micrometastases in sentinel lymph nodes. Br J Surg 89:1505-1515, 2002
42. Colleoni M, Rotmensz N, Peruzzotti G, et al: Size of breast cancer metastases in axillary lymph nodes: Clinical relevance of minimal lymph node involvement. J Clin Oncol 23:1379-1389, 2005
43. International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335:1565-1568, 1990
44. De Mascarel I, Bonichon F, Coindre JM, et al: Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Reevaluation with longer follow-up. Br J Cancer 66:523-527, 1992
45. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al: Detection and significance of occult metastases in node-negative breast cancer. Br J Surg 80:459-463, 1993
46. Cote RJ, Peterson HF, Chaiwun B, et al: Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet 354:896-900, 1999
47. Teng S, Dupont E, McCann C, et al: Do cytokeratin-positive only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Am Surg 66: 574-578, 2000
48. Wong SL, Edwards MJ, Chao C, et al: Predicting the status of the nonsentinel axillary nodes: A multicenter study. Arch Surg 136:563-568, 2001
49. Jakub JW, Diaz NM, Ebert MD: Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel nodes. Am J Surg 184:302-306, 2002
50. Bergkvist L, Frisell J, Liljegren G, et al: Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 88:1644-1648, 2001
51. Brenot-Rossi I, Houvenaeghel G, Jacquemier J, et al: Non visualisation of axillary sentinel node during lymphoscintigraphy: Is there a pathologic significance in breast cancer? J Nucl Med 44:1232-1237, 2003
52. Louis-Sylvestre C, Clough K, Asselain B, et al: Axillary treatment in conservative management of operable breast cancer: Dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 22:97-101, 2004
53. Haagensen CD: Diseases of the breast. New York, NY, Saunders, 1986, pp 911-913
54. Fisher B, Redmond C, Fisher E: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. New Engl J Surg 312:674-681, 1985
55. Fowble B, Solin LJ, Schultz DJ, et al: Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys 17:703-710, 1989
56. Siegel BM, Mayzel KA: Level I and II axillary dissection in the treatment of early-stage breast cancer: An analysis of 259 consecutive patients. Arch Surg 125:1144-1147, 1990
57. Recht A, Pierce SM, Abner A, et al: Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 9:988-996, 1991
58. Halverson KJ, Taylor ME, Perez CA, et al: Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 26:593-599, 1993
59. Chua B, Ung O, Boyages J: Competing considerations in regional nodal treatment for early breast cancer. Breast J 8:15-22, 2002
60. Fisher B, Jeon JH, Anderson S, et al: Twenty-five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by radiation. N Engl J Med 347:567-575, 2002
61. Giuliano AE, Haigh PI, Brennan MB, et al: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18:2553-2559, 2000
62. Veronesi U, Galimberti V, Zurrida S, et al: Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 37:454-458, 2001
63. Roumen RM, Kuijit GP, Liem IH, et al: Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 88:1639-1643, 2001
64. Reitsamer R, Peintinger F, Prokop E, et al: Sentinel lymph node biopsy alone without axillary lymph node dissection: Follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 29:221-223, 2003
65. Chung MA, Steinhoff MM, Cady B: Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 184:310-314, 2002
66. Blanchard DK, Donohue JH, Reynolds C, et al: Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482-487, 2003
67. Jeruss JS, Winchester DJ, Sener SF, et al: Axillary recurrence after sentinel node biopsy. Ann Surg Oncol 12:34-40, 2005
68. Smidt ML, Kuster DM, van der Wilt, et al: Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann surg Oncol 12:1066-1072, 2005